Federal Court of Australia
FEDERAL COURT OF AUSTRALIA
Reckitt Benckiser Healthcare (UK) Ltd v GlaxoSmithKline Australia Pty Ltd [2013] FCA 583 Citation: Reckitt Benckiser Healthcare (UK) Ltd v GlaxoSmithKline Australia Pty Ltd [2013] FCA 583
Parties: RECKITT BENCKISER HEALTHCARE (UK) LIMITED and RECKITT BENCKISER (AUSTRALIA) PTY LIMITED ABN 17 003 2274 655 v GLAXOSMITHKLINE AUSTRALIA PTY LTD ABN 47 100 162 481
File number: NSD 734 of 2013
Judge: RARES J
Date of judgment: 28 May 2013
Legislation: Federal Court of Australia Act 1976 (Cth) s 37M Patents Act 1990 (Cth) ss 22A, 116, 138(3)
Cases cited: Aon Risk Services Australia Limited v Australian National University (2009) 239 CLR 175 applied Apotex Pty Ltd v AstraZeneca AB (No. 4) [2013] FCA 162 referred to Australian Broadcasting Corporation v O'Neill (2006) 227 CLR 57 applied Beecham Group Limited v Bristol Laboratories Pty Limited (1968) 118 CLR 618 applied Interpharma Pty Ltd v Commissioner of Patents (2008) 79 IPR 261 applied Kimberly-Clark Australia Pty Limited v Arico Trading International Pty Limited (2001) 207 CLR 1 applied Welch Perrin & Co Pty Limited v Worrel (1961) 106 CLR 588 applied
Date of hearing: 27 and 28 May 2013
Place: Sydney
Division: GENERAL DIVISION
Category: No catchwords
Number of paragraphs: 61
Counsel for the Applicants: Ms K Howard SC with Mr JS Cooke
Solicitor for the Applicants: Corrs Chambers Westgarth
We try to embed the page this law was scraped from. If the site blocks framing, you still get the link and a local excerpt.
Last checked with source on —
Checking whether the official page can be embedded…
Plain-English simplify of this law: a short summary, key points, and both sides of the argument. Generated on first view via Replicate, then cached. Vote on what helps your study.
No study brief is cached for this law yet. Sign up to generate a plain-English brief.
Sign up to generate